ClinicalTrials.gg

Biological

Cipaglucosidase alfa clinical trials

Also written ATB200.

studies test it
4
open now
1
in phase 3
4
first study started
2018

Keep track of what changes. Save the cipaglucosidase alfa studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Development codes

Studies by the year they started

4 studies that test it; most in 2018 (1)

Studies that test cipaglucosidase alfa, by start year
YearStudies
20181
20191
20201
20231

By phase

A phase 1/2 study counts in both.

Phase 3
4

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 4 · Other 0

Amicus Therapeutics (4)

Often tested with

Tested in the same studies.

Miglustat (3) · AT2221 (1)

Studies

Open first, then newest update. How each study uses cipaglucosidase alfa is read from its arms, and is right about nine times in ten.

Testing it · 4

Given in every arm · 1 — cipaglucosidase alfa is usual care beside what is tested

Codes

What other systems call cipaglucosidase alfa · ClinicalTrials.gg INT002136

  • MeSH (NLM) C000731755cipaglucosidase alfaOne source NLM
  • UNII (FDA) 4SED7F4BSGCIPAGLUCOSIDASE ALFAConfirmed FDA, NLM
  • NCI Thesaurus C175059Cipaglucosidase AlfaOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.